
    
      This is a single-center, randomized, double-blind, placebo-controlled clinical trial. OCT
      coronary images analyzed at an independent imaging core laboratory (Department of Cardiology,
      Second Affiliated Hospital of Harbin Medical University, Harbin, China) by blinded expert
      readers.
    
  